Is the HCV-HIV co-infection prevalence amongst injecting drug users a marker for the level of sexual and injection related HIV transmission?

Vickerman, P; Martin, NK; Roy, A; Beattie, T; Jarlais, DD; Strathdee, S; Wiessing, L; Hickman, M; EMCDDA Collaborative Group; , COLLABORATORS; +36 more... Bao, YP; Caiaffa, W; Ralón, G; Rossi, D; Camoni, L; Suligoi, B; Bergant, N; Brehm Christensen, P; Duarte, Ó; Santos, S; Ribeiro, C; Eritsyan, K; Odinokova, V; Vyshinsky, K; Folch, C; Casabona, J; Fotiou, A; Hope, V; Horvath, I; Hutchinson, S; Bogdanova, V; Ilieva, R; Long, J; Matheï, C; Muravsky, A; Prasad, L; Barros, H; Rosinska, M; Roustide, MJ; Scutelniciuc, O; Strathdee, S; Vallejo, F; Uusküla, A; Guarita, B; Noor, A; de la Fuente, L; (2013) Is the HCV-HIV co-infection prevalence amongst injecting drug users a marker for the level of sexual and injection related HIV transmission? Drug and alcohol dependence, 132 (1-2). pp. 172-81. ISSN 0376-8716 DOI: https://doi.org/10.1016/j.drugalcdep.2013.01.020

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1016/j.drugalcdep.2013.01.020

Abstract

Share

Download

Full text not available from this repository.

Downloads

View details

Metrics & Citations


Google Scholar